This bill amends current law to increase the annual allocation of cigarette and other tobacco products tax revenues to the New Jersey Commission on Cancer Research (NJCCR) from $1 million to $10 million. It establishes a dedicated, non-lapsing Cancer Research Fund within the Department of the Treasury, which will serve as the repository for these funds and any additional funds approved by the Department of Health or the NJCCR. The bill mandates that at least $5 million of the fund be allocated for general cancer research and at least $5 million for pediatric cancer research, ensuring a focused approach to addressing cancer disparities among various racial and ethnic populations.

Additionally, the bill repeals the existing lapsing Cancer Research Fund and replaces it with the new non-lapsing, revolving fund. The State Treasurer will act as the custodian of this fund, overseeing all disbursements and ensuring that the funds are invested and managed in accordance with state law. This legislative change aims to enhance the NJCCR's capacity to fund vital cancer research initiatives and improve access to high-quality cancer care and treatment for vulnerable communities.

Statutes affected:
Introduced: 54:40A-37.1, 52:9U-8